Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Biomed Res Int ; 2014: 368107, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24987679

RESUMO

The aim of this work was to determine the effect of dietary n - 3 PUFA on oxidant/antioxidant status, in vitro very low and low density lipoprotein (VLDL-LDL), and VLDL-LDL-fatty acid composition in macrosomic pups of diabetic mothers. We hypothesized that n - 3 PUFA would improve oxidative stress in macrosomia. Diabetes was induced in female Wistar rats fed with the ISIO diet (control) or with the EPAX diet (enriched in n - 3 PUFAs), by streptozotocin. The macrosomic pups were killed at birth (day 0) and at adulthood (day 90). Lipid parameters and VLDL-LDL-fatty acid composition were investigated. The oxidant/antioxidant status was determined by measuring plasma oxygen radical absorbance capacity (ORAC), hydroperoxides, carbonyl proteins, and VLDL-LDL oxidation. Macrosomic rats of ISIO fed diabetic mothers showed an increase in plasma and VLDL-LDL-triglycerides and VLDL-LDL-cholesterol levels and altered VLDL-LDL-fatty acid composition. Plasma ORAC was low with high hydroperoxide and carbonyl protein levels. The in vitro oxidizability of VLDL-LDL was enhanced in these macrosomic rats. The EPAX diet corrected lipid parameters and improved oxidant/antioxidant status but increased VLDL-LDL susceptibility to oxidation. Macrosomia is associated with lipid abnormalities and oxidative stress. n - 3 PUFA exerts favorable effects on lipid metabolism and on the oxidant/antioxidant status of macrosomic rats. However, there are no evident effects on VLDL-LDL oxidation.


Assuntos
Diabetes Mellitus Experimental , Gorduras na Dieta/farmacologia , Ácidos Graxos Ômega-3/farmacologia , Macrossomia Fetal/sangue , Estresse Oxidativo/efeitos dos fármacos , Animais , Antioxidantes/metabolismo , Feminino , Macrossomia Fetal/dietoterapia , Masculino , Oxidantes/sangue , Oxirredução/efeitos dos fármacos , Ratos , Ratos Wistar
2.
Placenta ; 35(6): 411-6, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-24698544

RESUMO

OBJECTIVE: To determine oxidative stress markers in maternal obesity during pregnancy and to evaluate feto-placental unit interaction, especially predictors of fetal metabolic alterations. PATIENTS AND METHODS: 40 obese pregnant women (prepregnancy BMI > 30 kg/m²) were compared to 50 control pregnant women. Maternal, cord blood and placenta samples were collected at delivery. Biochemical parameters (total cholesterol and triglycerides) and oxidative stress markers (malondialdehyde, carbonyl proteins, superoxide anion expressed as reduced Nitroblue Tetrazolium, nitric oxide expressed as nitrite, reduced glutathione, catalase, superoxide dismutase) were assayed by biochemical methods. RESULTS: Maternal, fetal and placental triglyceride levels were increased in obese group compared to control. Maternal malondialdehyde, carbonyl proteins, nitric oxide and superoxide anion levels were high while reduced glutathione concentrations and superoxide dismutase activity were low in obesity. In the placenta and in newborns of these obese mothers, variations of redox balance were also observed indicating high oxidative stress. Maternal and placental interaction constituted a strong predictor of fetal redox variations in obese pregnancies. DISCUSSION: Maternal obesity compromised placental metabolism and antioxidant status which strongly impacted fetal redox balance. Oxidative stress may be one of the key downstream mediators that initiate programming of the offspring. CONCLUSION: Maternal obesity is associated with metabolic alterations and dysregulation of redox balance in the mother-placenta - fetus unit. These perturbations could lead to maternal and fetal complications and should be carefully considered.


Assuntos
Sangue Fetal/química , Troca Materno-Fetal , Obesidade/metabolismo , Estresse Oxidativo , Placenta/metabolismo , Complicações na Gravidez/metabolismo , Adulto , Biomarcadores/análise , Biomarcadores/sangue , Proteínas Sanguíneas/análise , Catalase/análise , Catalase/sangue , Colesterol/análise , Colesterol/sangue , Feminino , Glutationa/análise , Glutationa/sangue , Humanos , Recém-Nascido , Masculino , Malondialdeído/análise , Malondialdeído/sangue , Óxido Nítrico/análise , Óxido Nítrico/sangue , Obesidade/sangue , Oxirredução , Placenta/química , Gravidez , Proteínas/análise , Superóxido Dismutase/análise , Superóxido Dismutase/sangue , Superóxidos/análise , Superóxidos/sangue , Triglicerídeos/análise , Triglicerídeos/sangue
3.
Mol Cell Biochem ; 360(1-2): 23-33, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21877147

RESUMO

The aim of this work was to study the in vitro effects of δ-lactone 1, δ-lactam 3 and their enaminone derivatives 2 and 4, synthesized in our laboratory, on the proliferative responses of human lymphocytes, Th1 and Th2 cytokine secretion and intracellular redox status. Peripheral blood lymphocytes were isolated using differential centrifugation on a density gradient of Histopaque. They were cultured with mitogen concanavalin A (Con A) and with different concentrations of the compounds 1, 2, 3 and 4 (0.1-10 µM). Proliferation (MTT assay), IL-2, INFγ and IL-4 (Elisa kits), oxidative markers (intracellular glutathione, hydroperoxide and carbonyl protein contents) and cytotoxic effect (micronucleus test) were determined. The compounds 1 and 2 are immunosuppressive and decrease IL-2, INFγ and IL-4 secretion with a shift away from Th2 response to Th1 phenotype. The compounds 3 and 4 were immunostimulant and increased cytokine secretion with a shift away from Th1 response to Th2. The introduction of an enamine group to 1 and 3 to provide 2 and 4 seemed to attenuate their immunological properties. These immunomodulatory properties were, however, accompanied by an increase in lymphocyte intracellular oxidative stress, especially with 1 and 2 at high concentrations. In conclusion, the compounds 1, 2, 3 and 4 could be used to provide cell-mediated immune responses for novel therapies in T-cell mediated immune disorders.


Assuntos
Lactamas/farmacologia , Lactonas/farmacologia , Piridonas/farmacologia , Linfócitos T/efeitos dos fármacos , Adulto , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Citocinas/metabolismo , Feminino , Glutationa/metabolismo , Humanos , Peróxido de Hidrogênio/metabolismo , Lactamas/síntese química , Lactonas/síntese química , Masculino , Testes para Micronúcleos , Estresse Oxidativo , Carbonilação Proteica/efeitos dos fármacos , Piridonas/síntese química , Linfócitos T/metabolismo , Linfócitos T/fisiologia
4.
Arch Biochem Biophys ; 380(2): 243-50, 2000 Aug 15.
Artigo em Inglês | MEDLINE | ID: mdl-10933878

RESUMO

Hepatic stearoyl CoA desaturase (SCD) activity in chickens from a fat line is higher than that of chickens from a lean line and correlates with plasma triacylglycerol concentrations. Furthermore, in these lines, the hepatic SCD1 mRNA level is positively correlated with the adipose tissue weight. To analyze the contribution of the SCD1 gene in the regulation of adiposity in the early stages of triacylglycerol secretion, SCD1 coding sequence and antisense RNA expression vectors were transfected in LMH cells. After selection, these cells were analyzed with regard to SCD1 expression and lipid secretion. The amounts of secreted triacylglycerols and phospholipids were shown to be higher in LMH cells transfected with the SCD1 gene, but reduced in those transfected with the SCD1 antisense sequences when compared to cells transfected with the vector alone (without SCD1 sequences). These results provide direct evidence that the expression of the SCD1 gene plays a major role in the triacylglycerol and phospholipid secretion process.


Assuntos
Metabolismo dos Lipídeos , RNA Antissenso/farmacologia , Estearoil-CoA Dessaturase/genética , Animais , Sequência de Bases , Galinhas , Primers do DNA/genética , Expressão Gênica , Isoenzimas/genética , Isoenzimas/metabolismo , Fígado/efeitos dos fármacos , Fígado/enzimologia , Fígado/metabolismo , Neoplasias Hepáticas Experimentais/enzimologia , Neoplasias Hepáticas Experimentais/genética , Neoplasias Hepáticas Experimentais/metabolismo , RNA Antissenso/genética , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , RNA Neoplásico/genética , RNA Neoplásico/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Estearoil-CoA Dessaturase/metabolismo , Transfecção , Células Tumorais Cultivadas
5.
Mol Cell Biochem ; 132(1): 25-9, 1994 Mar 16.
Artigo em Inglês | MEDLINE | ID: mdl-8078505

RESUMO

The effects of age and hypertension on the antioxidant defence systems and the lipid peroxidation in rat isolated hepatocytes were studied. Four different age groups (1, 3, 6 and 12 months) were considered in spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto (WKY) rats. Age-associated changes were observed on vitamin E status, glutathione (GSH) level, MDA formation and glutathione peroxidase (GSH-Px) activity in both strains. Maximal levels or activities of these parameters were found at 3 and 6 months, except for MDA which was low at 3 months. Then, a fall was observed at 12-month-old compared to 6-month values. In addition, GSH-Px activity was significantly lower in SHR than in WKY rats, except at the age of one month. The decrease of this enzyme activity could induce an increased cellular generation of radical species and lipid peroxidation, which might be link to hypertension.


Assuntos
Envelhecimento/metabolismo , Antioxidantes/metabolismo , Peroxidação de Lipídeos/fisiologia , Fígado/metabolismo , Ratos Endogâmicos SHR/metabolismo , Animais , Glutationa/análise , Glutationa Peroxidase/metabolismo , Fígado/química , Masculino , Malondialdeído/análise , Ratos , Ratos Endogâmicos WKY , Tiobarbitúricos/análise , Vitamina E/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA